Sign inGet started

Pagan Douglas W.

Insider CIK 1628880 · ZIOP Director · PRTK Chief Financial Officer · DRNA Chief Financial Officer · KLRA Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KLRA Kailera Therapeutics, Inc. A Award deriv2026-04-162026-04-20100,000— $0100,000SEC↗
KLRA Kailera Therapeutics, Inc. A Award deriv2026-04-162026-04-20100,000— $0100,000SEC↗
DRNA Dicerna Pharmaceuticals In D To issuer deriv2021-12-282021-12-2995,650— $00SEC↗
DRNA Dicerna Pharmaceuticals In D To issuer deriv2021-12-282021-12-2936,900— $00SEC↗
DRNA Dicerna Pharmaceuticals In D To issuer deriv2021-12-282021-12-2920,475— $00SEC↗
DRNA Dicerna Pharmaceuticals In D To issuer deriv2021-12-282021-12-296,150— $00SEC↗
DRNA Dicerna Pharmaceuticals In U Tender2021-12-282021-12-297,775$38.25 $297.4K0SEC↗
DRNA Dicerna Pharmaceuticals In M Exercise deriv2021-12-152021-12-172,050— $06,150SEC↗
DRNA Dicerna Pharmaceuticals In F Tax w/h2021-12-152021-12-17602$38.05 $22.9K7,775SEC↗
DRNA Dicerna Pharmaceuticals In M Exercise2021-12-152021-12-172,050— $08,377SEC↗
DRNA Dicerna Pharmaceuticals In M Exercise deriv2021-06-152021-06-176,825— $020,475SEC↗
DRNA Dicerna Pharmaceuticals In M Exercise2021-06-152021-06-176,825— $07,764SEC↗
DRNA Dicerna Pharmaceuticals In F Tax w/h2021-06-152021-06-172,004$35.74 $71.6K5,760SEC↗
DRNA Dicerna Pharmaceuticals In A Award deriv2021-01-122021-01-128,200— $08,200SEC↗
DRNA Dicerna Pharmaceuticals In A Award deriv2021-01-122021-01-1236,900— $036,900SEC↗
DRNA Dicerna Pharmaceuticals In A Award deriv2020-06-012020-06-0227,300— $027,300SEC↗
DRNA Dicerna Pharmaceuticals In A Award deriv2020-06-012020-06-0295,650— $095,650SEC↗
ZIOP ZIOPHARM ONCOLOGY INC A Award deriv2019-12-312020-01-0325,281— $025,281SEC↗
ZIOP ZIOPHARM ONCOLOGY INC A Award2019-12-312020-01-0315,890— $055,997SEC↗
ZIOP ZIOPHARM ONCOLOGY INC F Tax w/h2019-12-312020-01-0320,054$4.72 $94.7K35,943SEC↗
PRTK Paratek Pharmaceuticals, I D To issuer2019-04-052019-04-0827,500— $087,057SEC↗
PRTK Paratek Pharmaceuticals, I D To issuer2019-04-052019-04-0819,500— $0151,557SEC↗
PRTK Paratek Pharmaceuticals, I D To issuer2019-04-052019-04-0816,250— $070,807SEC↗
PRTK Paratek Pharmaceuticals, I A Award2019-04-052019-04-0830,000— $0100,807SEC↗
PRTK Paratek Pharmaceuticals, I D To issuer2019-04-052019-04-0837,000— $0114,557SEC↗
PRTK Paratek Pharmaceuticals, I A Award2019-02-262019-02-2837,000— $0171,057SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2019-02-052019-02-072,495$6.77 $16.9K134,057SEC↗
PRTK Paratek Pharmaceuticals, I A Award2019-02-012019-02-0416,250— $0136,552SEC↗
ZIOP ZIOPHARM ONCOLOGY INC A Award deriv2018-12-312019-01-0263,350— $063,350SEC↗
ZIOP ZIOPHARM ONCOLOGY INC A Award2018-12-312019-01-0240,107— $040,107SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2018-12-122018-12-142,918$6.76 $19.7K120,302SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2018-10-152018-10-162,784$8.96 $24.9K123,220SEC↗
PRTK Paratek Pharmaceuticals, I A Award2018-10-122018-10-166,500— $0126,004SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2018-10-032018-10-047,579$9.82 $74.4K119,504SEC↗
PRTK Paratek Pharmaceuticals, I A Award2018-10-022018-10-0422,500— $099,583SEC↗
PRTK Paratek Pharmaceuticals, I A Award2018-10-022018-10-0427,500— $0127,083SEC↗
ZIOP ZIOPHARM ONCOLOGY INC A Award deriv2018-09-182018-09-2050,000— $050,000SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2018-04-092018-04-105,237$12.70 $66.5K77,083SEC↗
PRTK Paratek Pharmaceuticals, I A Award2018-04-032018-04-0513,500— $082,320SEC↗
PRTK Paratek Pharmaceuticals, I A Award2018-02-142018-02-1629,250— $068,820SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2018-02-052018-02-0716,291$14.22 $231.7K39,570SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2017-07-052017-07-064,139$23.58 $97.6K55,861SEC↗
PRTK Paratek Pharmaceuticals, I A Award2017-07-032017-07-069,000— $060,000SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2017-06-192017-06-214,595$25.00 $114.9K51,000SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2017-02-062017-02-0825$15.09 $37755,595SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2017-02-062017-02-081,186$15.05 $17.8K55,620SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2017-02-062017-02-0817$15.08 $25656,806SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2017-02-062017-02-081,428$15.10 $21.6K56,823SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2017-02-062017-02-08732$15.15 $11.1K58,251SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2017-02-062017-02-0817$15.20 $25858,983SEC↗
PRTK Paratek Pharmaceuticals, I A Award deriv2017-02-022017-02-0645,000— $045,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award deriv2016-02-042016-02-0848,000— $048,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award2016-02-042016-02-0824,000— $059,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award2015-02-042016-02-0835,000— $035,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award deriv2015-02-042015-02-06160,000— $0160,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award deriv2015-02-042015-02-0635,000— $035,000SEC↗